Early Day Notes: NCR Corporation (NYSE:NCR), Lincoln National Corporation (NYSE:LNC), Navistar International Corporation (NYSE:NAV), CytomX Therapeutics (NASDAQ:CTMX)

Insmed Incorporated (NASDAQ:INSM) shares decreased -4.57% in last trading session and ended the day at $16.72. INSM has a return on assets of -34.00%. Insmed Incorporated (NASDAQ:INSM) quarterly performance is -33.55%.

Insmed Incorporated (NASDAQ:INSM), reported that Will Lewis, president and chief executive officer of Insmed, participated in an analyst-led fireside chat discussion at the Piper Jaffray 27th Annual Healthcare Conference on Tuesday, December 1 at 2:30 PM ET in New York City.

NCR Corporation (NYSE:NCR) ended the last trading day at $26.60. Company weekly volatility is calculated as 2.11% and price to cash ratio as 14.92. NCR Corporation (NYSE:NCR) showed a weekly performance of 0.49%.

On 4 December, NCR Corporation (NYSE:NCR) announced that it has closed the previously announced transaction with Blackstone (BX), one of the world’s leading investment firms, pursuant to which affiliates of Blackstone invested $820 million in NCR in the form of perpetual convertible preferred shares. In connection with the closing of the transaction, the NCR board of directors expanded from 9 to 11 directors and NCR elected two new members to the board, Chinh Chu and Greg Blank.

On 11 December, Lincoln National Corporation (NYSE:LNC) shares decreased -4.00% and was closed at $50.62. LNC EPS growth in last 5 year was 40.70%. Lincoln National Corporation (NYSE:LNC) year to date (YTD) performance is -10.92%.

Lincoln Financial Group (NYSE: LNC) announced that its employees have raised approximately $1.1 million for United Way organizations across the country during its annual month-long campaign, which took place in October. Lincoln Financial’s employees were invited to participate in the campaign, a tradition that spans three decades and is an extension of the company’s philanthropic efforts – through the Lincoln Financial Foundation – to enhance local communities.

Navistar International Corporation (NYSE:NAV) shares decreased -5.55% in last trading session and ended the day at $8.85. NAV Gross Margin is 13.60% and its has a return on assets of -3.00%. Navistar International Corporation (NYSE:NAV) quarterly performance is -51.02%.

Zacks Investment Research cut shares of Navistar International Corp (NYSE:NAV) from a hold rating to a strong sell rating in a report issued on Monday morning, AnalystRatings.NET reports.

CytomX Therapeutics, Inc. (NASDAQ:CTMX) caters to the Healthcare space. Its weekly performance is -19.15%. On the last day of trading company shares ended up at $19.13. CytomX Therapeutics, Inc. (NASDAQ:CTMX) distance from 50-day simple moving average (SMA50) is 5.05%.

CytomX Therapeutics, Inc. (NASDAQ:CTMX), announced that it presented at Oppenheimer’s 26th Annual Healthcare Conference in New York. Bob Goeltz, chief financial officer, and Rachel Humphrey, M.D., chief medical officer, delivered a corporate overview at 9:10 a.m. EST on Tuesday, December 8.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *